Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival
- 4 November 2010
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 25 (8), 917-921
- https://doi.org/10.1111/j.1468-3083.2010.03880.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efficacy of Botulinum Toxin Type A in the Treatment of Focal Axillary HyperhidrosisDermatologic Surgery, 2008
- Evidence for effectiveness of botulinum toxin for hyperhidrosisJournal of Neural Transmission, 2007
- A Comprehensive Approach to the Recognition, Diagnosis, and Severity-Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory CommitteeDermatologic Surgery, 2007
- Definition of disease-free survival: this is my truth–show me yoursAnnals Of Oncology, 2005
- Treatment of palmar hyperhidrosis with botulinum toxin type A: 44 months of experienceJournal of Cosmetic Dermatology, 2005
- Focal hyperhidrosis: diagnosis and managementCMAJ : Canadian Medical Association Journal, 2005
- The place of botulinum toxin type A in the treatment of focal hyperhidrosisBritish Journal of Dermatology, 2004
- Hyperhidrosis and botulinum toxin A: patient selection and techniquesClinics in Dermatology, 2004
- Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlledBMJ, 2001
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994